Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
Amina Essawy EssawyOryhan Aly Abou-ElNagaRadwa Ali MehannaNoha Mohammed BadaeEman Sheta ElsawyAhmed Abdelmagied SoffarPublished in: PloS one (2024)
Parkinson's disease (PD) is one of the most common neurodegenerative diseases worldwide. Currently applied therapeutic protocols are limited to improve the motor functions of patients. Therefore, seeking alternative regimes with better therapeutic impact is crucial. This study aims to validate the therapeutic impact of mesenchymal stem cell injection using two delivery methods, intracranial administration and intravenous administration, on rotenone (ROT)-induced PD model in rats. Our work included behavioral, biochemical, histological, and molecular investigations. Open field test (OFT) and rotarod tests were applied. Important oxidative stress, antioxidant and proinflammatory markers were monitored. Substantia Nigra and Striatum tissues were examined histologically and the molecular expression of DOPA decarboxylase, Tyrosine hydroxylase, and α-synuclein in neurons in these tissues were investigated. Our results showed that MSC grafting improved motor and memory impairments and oxidative stress status that were observed after ROT administration. Additionally, BM-MSCs application restored SOD and CAT activities and the levels of DA, L-Dopa, IL6, IL1β, and TNFα. Moreover, MSC grafting overwhelmed the pathological changes induced by ROT and normalized the expression of Tyrosine hydroxylase, DOPA decarboxylase, and α-synuclein towards the control values in the Nigral and Striatal tissues of male rats. Conclusively, both administration routes improved motor function, protection of the nigrostriatal system, and improved striatal dopamine release. The observed beneficial effect of applying MSCs suggests potential benefits in clinical applications. No significant differences in the outcomes of the treatment would favor a certain way of MSC application over the other. However, the intravenous delivery method seems to be safer and more feasible compared to the intrastriatal method.
Keyphrases
- mesenchymal stem cells
- oxidative stress
- umbilical cord
- diabetic rats
- poor prognosis
- gene expression
- high dose
- parkinson disease
- end stage renal disease
- bone marrow
- cell therapy
- ejection fraction
- chronic kidney disease
- functional connectivity
- rheumatoid arthritis
- newly diagnosed
- ischemia reperfusion injury
- drug induced
- prognostic factors
- single molecule
- spinal cord
- mass spectrometry
- stem cells
- induced apoptosis
- binding protein
- type diabetes
- working memory
- weight loss
- atomic force microscopy
- low dose
- metabolic syndrome
- ultrasound guided
- endoplasmic reticulum stress
- skeletal muscle
- risk assessment
- signaling pathway
- long non coding rna
- anti inflammatory
- endothelial cells
- stress induced
- patient reported outcomes
- insulin resistance
- high speed